229 related articles for article (PubMed ID: 25714513)
1. A pilot cost-effectiveness analysis of treatments in newly diagnosed high-grade gliomas: the example of 5-aminolevulinic Acid compared with white-light surgery.
Esteves S; Alves M; Castel-Branco M; Stummer W
Neurosurgery; 2015 May; 76(5):552-62; discussion 562. PubMed ID: 25714513
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of 5-aminolevulinic acid-induced fluorescence in malignant glioma surgery.
Slof J; Díez Valle R; Galván J
Neurologia; 2015 Apr; 30(3):163-8. PubMed ID: 24468659
[TBL] [Abstract][Full Text] [Related]
3. 5-Aminolevulinic Acid Hydrochloride (5-ALA)-Guided Surgical Resection of High-Grade Gliomas: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2020; 20(9):1-92. PubMed ID: 32194883
[TBL] [Abstract][Full Text] [Related]
4. The effectiveness and cost-effectiveness of intraoperative imaging in high-grade glioma resection; a comparative review of intraoperative ALA, fluorescein, ultrasound and MRI.
Eljamel MS; Mahboob SO
Photodiagnosis Photodyn Ther; 2016 Dec; 16():35-43. PubMed ID: 27491856
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of preoperative motor mapping with navigated transcranial magnetic brain stimulation in patients with high-grade glioma.
Butenschön VM; Ille S; Sollmann N; Meyer B; Krieg SM
Neurosurg Focus; 2018 Jun; 44(6):E18. PubMed ID: 29852777
[TBL] [Abstract][Full Text] [Related]
6. Carmustine implants for the treatment of newly diagnosed high-grade gliomas: a cost-utility analysis.
Rogers G; Garside R; Mealing S; Pitt M; Anderson R; Dyer M; Stein K; Somerville M
Pharmacoeconomics; 2008; 26(1):33-44. PubMed ID: 18088157
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of radiation and chemotherapy for high-risk low-grade glioma.
Qian Y; Maruyama S; Kim H; Pollom EL; Kumar KA; Chin AL; Harris JP; Chang DT; Pitt A; Bendavid E; Owens DK; Durkee BY; Soltys SG
Neuro Oncol; 2017 Nov; 19(12):1651-1660. PubMed ID: 28666368
[TBL] [Abstract][Full Text] [Related]
8. Impact of the combination of 5-aminolevulinic acid-induced fluorescence with intraoperative magnetic resonance imaging-guided surgery for glioma.
Tsugu A; Ishizaka H; Mizokami Y; Osada T; Baba T; Yoshiyama M; Nishiyama J; Matsumae M
World Neurosurg; 2011; 76(1-2):120-7. PubMed ID: 21839963
[TBL] [Abstract][Full Text] [Related]
9. Intraoperative 5-ALA fluorescence-guided resection of high-grade glioma leads to greater extent of resection with better outcomes: a systematic review.
Eatz TA; Eichberg DG; Lu VM; Di L; Komotar RJ; Ivan ME
J Neurooncol; 2022 Jan; 156(2):233-256. PubMed ID: 34989964
[TBL] [Abstract][Full Text] [Related]
10. Counterbalancing risks and gains from extended resections in malignant glioma surgery: a supplemental analysis from the randomized 5-aminolevulinic acid glioma resection study. Clinical article.
Stummer W; Tonn JC; Mehdorn HM; Nestler U; Franz K; Goetz C; Bink A; Pichlmeier U;
J Neurosurg; 2011 Mar; 114(3):613-23. PubMed ID: 20397896
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of Intraoperative MRI for Treatment of High-Grade Gliomas.
Abraham P; Sarkar R; Brandel MG; Wali AR; Rennert RC; Lopez Ramos C; Padwal J; Steinberg JA; Santiago-Dieppa DR; Cheung V; Pannell JS; Murphy JD; Khalessi AA
Radiology; 2019 Jun; 291(3):689-697. PubMed ID: 30912721
[TBL] [Abstract][Full Text] [Related]
12. Endoscopic-assisted visualization of 5-aminolevulinic acid-induced fluorescence in malignant glioma surgery: a technical note.
Rapp M; Kamp M; Steiger HJ; Sabel M
World Neurosurg; 2014; 82(1-2):e277-9. PubMed ID: 23871813
[TBL] [Abstract][Full Text] [Related]
13. Safety and Efficacy of 5-Aminolevulinic Acid for High Grade Glioma in Usual Clinical Practice: A Prospective Cohort Study.
Teixidor P; Arráez MÁ; Villalba G; Garcia R; Tardáguila M; González JJ; Rimbau J; Vidal X; Montané E
PLoS One; 2016; 11(2):e0149244. PubMed ID: 26885645
[TBL] [Abstract][Full Text] [Related]
14. A prospective Phase II clinical trial of 5-aminolevulinic acid to assess the correlation of intraoperative fluorescence intensity and degree of histologic cellularity during resection of high-grade gliomas.
Lau D; Hervey-Jumper SL; Chang S; Molinaro AM; McDermott MW; Phillips JJ; Berger MS
J Neurosurg; 2016 May; 124(5):1300-9. PubMed ID: 26544781
[TBL] [Abstract][Full Text] [Related]
15. 5-Aminolevulinic acid for recurrent malignant gliomas: A systematic review.
Broekx S; Weyns F; De Vleeschouwer S
Clin Neurol Neurosurg; 2020 Aug; 195():105913. PubMed ID: 32447151
[TBL] [Abstract][Full Text] [Related]
16. The Cost-Effectiveness of 5-ALA in High-Grade Glioma Surgery: A Quality-Based Systematic Review.
Warsi NM; Zewude R; Karmur B; Pirouzmand N; Hachem L; Mansouri A
Can J Neurol Sci; 2020 Nov; 47(6):793-799. PubMed ID: 32329422
[TBL] [Abstract][Full Text] [Related]
17. Is fluorescence-guided surgery with 5-ala in eloquent areas for malignant gliomas a reasonable and useful technique?
Picart T; Armoiry X; Berthiller J; Dumot C; Pelissou-Guyotat I; Signorelli F; Guyotat J
Neurochirurgie; 2017 Jun; 63(3):189-196. PubMed ID: 28522184
[TBL] [Abstract][Full Text] [Related]
18. Observational, retrospective study of the effectiveness of 5-aminolevulinic acid in malignant glioma surgery in Spain (The VISIONA study).
Díez Valle R; Slof J; Galván J; Arza C; Romariz C; Vidal C;
Neurologia; 2014 Apr; 29(3):131-8. PubMed ID: 23870657
[TBL] [Abstract][Full Text] [Related]
19. 5-aminolevulinic acid (5-ALA) fluorescence guided surgery of high-grade gliomas in eloquent areas assisted by functional mapping. Our experience and review of the literature.
Della Puppa A; De Pellegrin S; d'Avella E; Gioffrè G; Rossetto M; Gerardi A; Lombardi G; Manara R; Munari M; Saladini M; Scienza R
Acta Neurochir (Wien); 2013 Jun; 155(6):965-72; discussion 972. PubMed ID: 23468036
[TBL] [Abstract][Full Text] [Related]
20. Shunt surgery in idiopathic normal pressure hydrocephalus is cost-effective-a cost utility analysis.
Tullberg M; Persson J; Petersen J; Hellström P; Wikkelsø C; Lundgren-Nilsson Å
Acta Neurochir (Wien); 2018 Mar; 160(3):509-518. PubMed ID: 29150794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
